Versant Capital Management’s Keros Therapeutics KROS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-643
Closed -$6.55K 2685
2025
Q1
$6.55K Buy
+643
New +$6.55K ﹤0.01% 1919